Vericel (VCEL) Change in Receivables (2010 - 2026)
Vericel (VCEL) reported Change in Receivables of -$12.3 million for Q1 2026, down 44.54% on a YoY basis from -$22.1 million in Q1 2025, and down 150.61% sequentially from $24.2 million in Q4 2025.
Vericel (VCEL) Change in Receivables (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 16 years of Change in Receivables data on file, last reported at -$12.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 44.54% year-over-year to -$12.3 million; the trailing twelve-month figure through Mar 2026 stood at $19.5 million (up 557.13% YoY), and the FY2025 full-year result was $23.3 million, up 670.42% from the prior year.
- Change in Receivables eased to -$12.3 million in Q1 2026, from $24.2 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $24.2 million in Q4 2025 to a low of -$12.3 million in Q1 2026.
- A 5-year average of $2.1 million and a median of $483000.0 in 2024 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables tumbled 4745.0% in 2024 and surged 687.77% in 2025, its largest moves.
- Tracing VCEL's Change in Receivables over 5 years: stood at $12.2 million in 2022, then soared by 52.14% to $18.6 million in 2023, then tumbled by 30.77% to $12.9 million in 2024, then soared by 87.72% to $24.2 million in 2025, then plunged by 150.61% to -$12.3 million in 2026.
- Business Quant data shows VCEL's Change in Receivables at -$12.3 million in Q1 2026, $24.2 million in Q4 2025, and -$3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | -12.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.25 Mn |
| Mar 31, 2026 | -12.25 Mn |
| Dec 31, 2025 | 24.21 Mn |
| Dec 31, 2025 | 24.21 Mn |
| Sep 30, 2025 | -3.86 Mn |
| Sep 30, 2025 | -3.86 Mn |
| Jun 30, 2025 | 11.39 Mn |
| Jun 30, 2025 | 11.39 Mn |
| Mar 31, 2025 | -8.48 Mn |
| Mar 31, 2025 | -8.48 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Sep 30, 2024 | 483,000.00 |
| Sep 30, 2024 | 483,000.00 |
| Jun 30, 2024 | -1.94 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | -8.42 Mn |
| Mar 31, 2024 | -8.42 Mn |
| Dec 31, 2023 | 18.63 Mn |
| Dec 31, 2023 | 18.63 Mn |